Association between stomatitis and treatment efficacy with novel TROP2-directed antibody drug conjugate (ADC), datopotamab deruxtecan, in patients with metastatic cancer

被引：0
|
作者：
Abelman, Rachel O.
Spring, Laura M.
Ryan, Phoebe K.
Fell, Geoffrey
Juric, Dejan
Heist, Rebecca S.
Bardia, Aditya
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5459
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor Cells
    Okajima, Daisuke
    Yasuda, Satoru
    Maejima, Takanori
    Karibe, Tsuyoshi
    Sakurai, Ken
    Aida, Tetsuo
    Toki, Tadashi
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Fujitani, Tomomichi
    Honda, Tomoyo
    Shibutani, Tomoko
    Muramatsu, Sumie
    Nakada, Takashi
    Goto, Riki
    Takahashi, Shu
    Yamaguchi, Miki
    Hamada, Hirofumi
    Noguchi, Yutaka
    Murakami, Masato
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12) : 2329 - 2340
  • [2] Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial
    Bardia, A.
    Juric, D.
    Shimizu, T.
    Tolcher, A.
    Karim, R.
    Spira, A.
    Mukohara, T.
    Lisberg, A. E.
    Kogawa, T.
    Krop, I.
    Papadopoulos, K. P.
    Hamilton, E.
    Damodaran, S.
    Greenberg, J.
    Gu, W.
    Kobayashi, F.
    Guevara, F.
    Jikoh, T.
    Kawasaki, Y.
    Meric-Bernstam, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S60 - S60
  • [3] TROPION-PanTumor01: Dose analysis of the TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd, DS-1062) for the treatment (Tx) of advanced or metastatic non-small cell lung cancer (NSCLC).
    Meric-Bernstam, Funda
    Spira, Alexander I.
    Lisberg, Aaron Elliott
    Sands, Jacob
    Yamamoto, Noboru
    Johnson, Melissa Lynne
    Yoh, Kiyotaka
    Garon, Edward B.
    Heist, Rebecca Suk
    Petrich, Adam
    Greenberg, Jonathan
    Tajima, Naoyuki
    Kawasaki, Yui
    Gu, Jessie
    Kobayashi, Fumiaki
    Lu, Yasong
    Guevara, Ferdinand M.
    Shimizu, Toshio
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
    Schipilliti, Francesca Matilde
    Drittone, Denise
    Mazzuca, Federica
    La Forgia, Daniele
    Guven, Deniz Can
    Rizzo, Alessandro
    HELIYON, 2024, 10 (07)
  • [5] Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
    McNamara, Blair
    Greenman, Michelle
    Bellone, Stefania
    Santin, Luca A.
    Demirkiran, Cem
    Mutlu, Levent
    Hartwich, Tobias Max Philipp
    Yang-Hartwich, Yang
    Ratner, Elena
    Schwartz, Peter E.
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY, 2024, 189 : 16 - 23
  • [6] Preclinical activity of datopotamab deruxtecan, a novel trophoblast cell-surface antigen 2 (TROP2) directed antibody-drug conjugate targeting TROP2 in high grade serous ovarian carcinoma
    Mcnamara, Blair
    Greenman, Michelle
    Bellone, Stefania
    Demirkiran, Cem
    Mutlu, Levent
    Hartwich, Tobias
    Yang-Hartwich, Yang
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A91 - A91
  • [7] Development of Triple-negative breast cancer (TNBC) syngeneic models and TROP2-directed antibody-drug conjugate (ADC) surrogate to model therapeutic combinations
    Chou, Chih-Chien
    Kardos, Jordan
    Yang, Becky
    Orf, Jessica
    Dave, Rutwij
    Lai, Yurong
    Lee, Chingwei V.
    Papalia, Giuseppe A.
    Boyd, Kelli
    Diehl, Lauri
    Scholler, Nathalie
    CANCER RESEARCH, 2023, 83 (05)
  • [8] TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
    Xu, Caili
    Zhu, Min
    Wang, Qian
    Cui, Jiajun
    Huang, Yuping
    Huang, Xiting
    Huang, Jing
    Gai, Junwei
    Li, Guanghui
    Qiao, Peng
    Zeng, Xian
    Ju, Dianwen
    Wan, Yakun
    Zhang, Xuyao
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [9] TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
    Caili Xu
    Min Zhu
    Qian Wang
    Jiajun Cui
    Yuping Huang
    Xiting Huang
    Jing Huang
    Junwei Gai
    Guanghui Li
    Peng Qiao
    Xian Zeng
    Dianwen Ju
    Yakun Wan
    Xuyao Zhang
    Journal of Nanobiotechnology, 21
  • [10] Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models
    Meric-Bernstam, Funda
    Yuca, Erkan
    Evans, Kurt W.
    Zhao, Ming
    Maejima, Takanori
    Karibe, Tsuyoshi
    Raso, Maria Gabriela
    Tang, Ximing
    Zheng, Xiaofeng
    Rizvi, Yasmeen Qamar
    Akcakanat, Argun
    Scott, Stephen M.
    Wang, Bailiang
    Byers, Lauren A.
    Tripathy, Debu
    Okajima, Daisuke
    Damodaran, Senthil
    CLINICAL CANCER RESEARCH, 2025, 31 (03) : 573 - 587
12345